NCT07739446

Brief Summary

The goal of this clinical trial is to evaluate the efficacy of surgical masks in preventing acute respiratory tract infections. The main question it aims to answer is: \- Does wearing a mask prevent you from getting acute respiratory tract infections, including influenza and COVID-19 Researchers will compare a surgical mask to no intervention to see if wearing a mask works to prevent acute respiratory infection. Participants will:

  • Wear or not wear a surgical mask every day
  • Answer a questionnaire every 2 weeks on symptoms, testing status, and behaviors This trial does not assess if wearing a mask prevents transmission of pathogens when you are already sick. Also, the trial does not assess whether universal masking (where everyone wears masks) works.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Jul 2026Mar 2027

Study Start

First participant enrolled

July 1, 2026

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

July 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 28, 2026

Last Update Submit

July 30, 2026

Conditions

Keywords

acute respiratory infectionsinfluenzaCOVID - 19public health and social measuressurgical maskmedical mask

Outcome Measures

Primary Outcomes (1)

  • Laboratory-confirmed influenza

    Laboratory-confirmed influenza based on testing done at healthcare facilities

    From start of influenza season to the end of data collection at 14 weeks

Secondary Outcomes (3)

  • Acute respiratory infection

    From start of influenza season to the end of data collection at 14 weeks

  • Laboratory-confirmed COVID-19

    From start of influenza season to the end of data collection at 14 weeks

  • Laboratory-confirmed influenza or COVID-19

    From start of influenza season to the end of data collection at 14 weeks

Other Outcomes (1)

  • Antibody response in sebum specimens

    From start of influenza season to the end of data collection at 14 weeks

Study Arms (2)

Surgical mask

EXPERIMENTAL

Participants in this group are provided with masks and asked to wear them every day

Behavioral: Surgical masks

No intervention

NO INTERVENTION

Participants in this group are not provided with masks and are asked not to wear them every day

Interventions

Surgical masksBEHAVIORAL

Participants in this group are provided with masks and asked to wear them every day

Surgical mask

Eligibility Criteria

Age20 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Those who originally do not wear a mask during the influenza season
  • Those aged 20 years or older and under 50 years at the time of providing informed consent
  • If assigned to the mask group, those who can agree to wear a mask when going outdoors for 3 to 4 months during the influenza season (excluding times such as when eating)
  • In the case of the non-mask group, those who can agree, in principle, not to wear a mask for 3 to 4 months during the influenza season
  • Those who can agree to undergo testing for both influenza and COVID-19 on the day of onset or the following day if symptoms suggestive of influenza, COVID-19, or a common cold (such as fever or respiratory symptoms) develop, and to visit a medical institution at their own expense for medical fees
  • Those who usually go out 3 or more days a week
  • Those who have obtained the agreement of cohabiting family members regarding participation
  • Those who, after receiving a thorough explanation regarding participation in this study and with full understanding, have provided written informed consent based on their own free will

You may not qualify if:

  • Those who originally wear a mask during the influenza season and intend to continue doing so in the future
  • Those who are engaged in healthcare, food manufacturing, etc., and wear a mask during regular work
  • Those who are pregnant
  • Those with underlying medical conditions such as chronic liver disease, cancer, or cardiovascular disease
  • Those who have previously experienced allergic symptoms when wearing commercially available non-woven masks
  • Those who are planning long-term overseas travel exceeding one week during the influenza season, including the New Year holidays‡
  • Others who did not provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chiba University/National Institute of Infectious Diseases, Japan Institute for Health Security

Chiba, Japan

Location

MeSH Terms

Conditions

Influenza, HumanCOVID-19

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract DiseasesPneumonia, ViralPneumoniaCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsLung Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 28, 2026

First Posted

July 31, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

The datasets generated and/or analyzed during the current study are not publicly available due to privacy regulations protecting participant confidentiality and identifiable data.

Locations